NRX Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wilmington, DE
SEC filing record 1 source field available
Fiscal year end
31 December
NRX Pharmaceuticals, Inc. has filed 466 SEC EDGAR filings since 13 Oct 2017

SEC filing history

Showing 176-200 of 466 matching filings.

Per page
25
Current page
8
4

PRIMARY DOCUMENT

Filing date
18 Nov 2022
Reporting date
16 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Nov 2022
Reporting date
11 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90195

SC 13D filing

Filing date
13 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Aug 2022
Reporting date
29 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B7 File 333-264201

FORM 424B7

Filing date
25 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
22 Jul 2022
Reporting date
12 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
29 Jun 2022
Reporting date
13 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-265492

EFFECT filing

Filing date
21 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38302

DEF 14A

Filing date
21 Jun 2022
Reporting date
18 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90195

SC 13D/A filing

Filing date
17 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38302

DEFA14A

Filing date
16 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-265492

S-3/A

Filing date
14 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .